Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

ViVerita Therapeutics Enters into Collaboration with Boehringer Ingelheim to Discovery of Novel Cancer Targets

Thursday, May 08, 2025

ViVerita Therapeutics has announced a new research collaboration with Boehringer Ingelheim The partnership aims to speed up the discovery and validation of new therapeutic targets in cancer treatment

BioVaxys and Sona Nanotech Collaboration on Cancer Therapeutics

Thursday, May 08, 2025

BioVaxys Technology and Sona Nanotech have entered a research agreement to jointly explore new cancer treatment approachesThis collaboration will focus on combining BioVaxys DPX Immune Educating Platform with Sonas Targeted Hyperthermia Therapy THT

Adcentrx Therapeutics Receives FDA Fast Track Designation for Nectin-4 ADC in Advanced Cervical Cancer

Wednesday, May 07, 2025

Adcentrx Therapeutics has been granted Fast Track designation by the US Food and Drug Administration FDA for its investigational therapy ADRX ADRX is a proprietary ADC created by Adcentrx using its iConjugation technology platform

Genezen and Optieum Biotechnologies Partnership to Advance CAR-T Therapy for Glioblastoma

Tuesday, May 06, 2025

Genezen has entered into a partnership with Optieum Biotechnologies The collaboration aims to support the current Good Manufacturing Practice cGMP manufacturing of a lentiviral vector LVV construct for OPTF an innovative CART therapy being developed...

Alterity Therapeutics Granted FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy

Monday, May 05, 2025

Alterity Therapeutics has been granted Fast Track designation by the US Food and Drug Administration FDA for its lead candidate ATH

Illumina and Ovation.io Introduce Novel Clinical Dataset to Tackle GLP-1 Treatment Challenges

Friday, May 02, 2025

Illumina and Ovationio have announced the creation of a major new clinical multiomic dataset focused on glucagonlike peptide GLP receptor agonist therapies

Dimerix Enters into Agreement with Amicus Therapeutics for DMX-200 to Treat FSGS

Thursday, May 01, 2025

Dimerix Limited and Amicus Therapeutics have entered an exclusive licensing agreement for the US commercialisation of DMX a Phase investigational treatment for Focal Segmental Glomerulosclerosis FSGS and other indications

Johnson & Johnson Receives FDA Approval for IMAAVY™ to Treat Generalised Myasthenia Gravis

Thursday, May 01, 2025

Johnson Johnson has announced that the US Food and Drug Administration FDA has approved IMAAVY nipocalimabaahu a monoclonal antibody that blocks the neonatal Fc receptor FcRn for the treatment of generalised myasthenia gravis gMG

Addex Enters into Agreement with Sinntaxis to Develop mGlu5 Inhibitors in Brain Injury Recovery

Wednesday, April 30, 2025

Addex Therapeutics has signed an option and collaboration agreement with Sinntaxis AB Recovery after a stroke or brain injury depends on the brains ability to form new connections or reactivate existing ones

QIAGEN Expands Digital PCR Tools for Lentivirus Quality Control

Wednesday, April 30, 2025

QIAGEN has expanded its digital PCR dPCR portfolio with new solutions for lentivirusbased applications which are widely used in the manufacture of advanced treatments such as CART cell therapy a form of personalised cancer immunotherapy